NM_020376.4:c.964C>T

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_020376.4(PNPLA2):​c.964C>T​(p.Leu322Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,610,926 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L322L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00076 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 2 hom. )

Consequence

PNPLA2
NM_020376.4 missense

Scores

19

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:2

Conservation

PhyloP100: 0.0530

Publications

4 publications found
Variant links:
Genes affected
PNPLA2 (HGNC:30802): (patatin like phospholipase domain containing 2) This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
PNPLA2 Gene-Disease associations (from GenCC):
  • neutral lipid storage myopathy
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0072030425).
BP6
Variant 11-824042-C-T is Benign according to our data. Variant chr11-824042-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 306305.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.000755 (115/152300) while in subpopulation SAS AF = 0.00166 (8/4830). AF 95% confidence interval is 0.000968. There are 0 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PNPLA2NM_020376.4 linkc.964C>T p.Leu322Phe missense_variant Exon 8 of 10 ENST00000336615.9 NP_065109.1 Q96AD5-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PNPLA2ENST00000336615.9 linkc.964C>T p.Leu322Phe missense_variant Exon 8 of 10 1 NM_020376.4 ENSP00000337701.4 Q96AD5-1

Frequencies

GnomAD3 genomes
AF:
0.000756
AC:
115
AN:
152182
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000981
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00165
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00118
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000816
AC:
198
AN:
242662
AF XY:
0.00102
show subpopulations
Gnomad AFR exome
AF:
0.000195
Gnomad AMR exome
AF:
0.000117
Gnomad ASJ exome
AF:
0.000204
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000692
Gnomad NFE exome
AF:
0.00116
Gnomad OTH exome
AF:
0.00136
GnomAD4 exome
AF:
0.00124
AC:
1802
AN:
1458626
Hom.:
2
Cov.:
37
AF XY:
0.00123
AC XY:
896
AN XY:
725548
show subpopulations
African (AFR)
AF:
0.000120
AC:
4
AN:
33446
American (AMR)
AF:
0.000247
AC:
11
AN:
44612
Ashkenazi Jewish (ASJ)
AF:
0.000115
AC:
3
AN:
26090
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39626
South Asian (SAS)
AF:
0.00161
AC:
138
AN:
85962
European-Finnish (FIN)
AF:
0.000778
AC:
40
AN:
51390
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5764
European-Non Finnish (NFE)
AF:
0.00136
AC:
1517
AN:
1111490
Other (OTH)
AF:
0.00138
AC:
83
AN:
60246
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
106
211
317
422
528
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
60
120
180
240
300
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000755
AC:
115
AN:
152300
Hom.:
0
Cov.:
33
AF XY:
0.000792
AC XY:
59
AN XY:
74460
show subpopulations
African (AFR)
AF:
0.000216
AC:
9
AN:
41580
American (AMR)
AF:
0.000980
AC:
15
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5154
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4830
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00118
AC:
80
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
6
12
18
24
30
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00104
Hom.:
0
Bravo
AF:
0.000820
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00116
AC:
10
ExAC
AF:
0.000778
AC:
94
EpiCase
AF:
0.00180
EpiControl
AF:
0.00143

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Neutral lipid storage myopathy Uncertain:1Benign:1
Jan 21, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

not provided Uncertain:1Benign:1
Feb 02, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PNPLA2: BP4 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.60
T
BayesDel_noAF
Benign
-0.67
CADD
Benign
13
DANN
Benign
0.94
DEOGEN2
Benign
0.22
T
Eigen
Benign
-0.95
Eigen_PC
Benign
-0.94
FATHMM_MKL
Benign
0.089
N
LIST_S2
Benign
0.70
T
M_CAP
Benign
0.050
D
MetaRNN
Benign
0.0072
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.66
N
PhyloP100
0.053
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-1.0
N
REVEL
Benign
0.021
Sift
Benign
0.48
T
Sift4G
Benign
0.27
T
Polyphen
0.0030
B
Vest4
0.18
MVP
0.092
MPC
0.24
ClinPred
0.0031
T
GERP RS
-0.41
Varity_R
0.025
gMVP
0.45
Mutation Taster
=81/19
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137866968; hg19: chr11-824042; API